Fentanyl Withdrawal: Timeline, Symptoms, and How It Differs From Heroin

What is fentanyl withdrawal?

Pharmacologically, it is ordinary opioid withdrawal: the same receptors, the same symptoms, the same basic treatment. What is different is practical: how long fentanyl lingers, how hard it is to start buprenorphine on top of it, and the sedatives that now come in the same bag.

MedlinePlus describes opioid withdrawal as very uncomfortable but not life threatening. Opioid withdrawal is rarely fatal by itself, but tolerance falls within days, so a return to a former dose can be fatal. With fentanyl, that former dose is impossible to judge, because nobody knows what the next bag holds.

This page covers how fentanyl withdrawal runs. Our opioid detox guide covers where to go in New Jersey, which programs are licensed for it, and who pays.

Fentanyl withdrawal symptoms

MedlinePlus splits opioid withdrawal into early and late symptoms.

Craving runs underneath all of it. A 2024 JAMA Internal Medicine review of hospital care in the fentanyl era says fentanyl’s high potency intensifies pain, withdrawal, and cravings, and that traditional ways of managing withdrawal and starting buprenorphine or methadone have not been enough for some patients.

The medical risk inside withdrawal is fluid loss. MedlinePlus notes that vomiting and diarrhea can cause dehydration and mineral imbalances. Someone who cannot keep fluids down needs medical care the same day, and vomiting that will not stop is a reason to call 911.

Fentanyl withdrawal timeline

We found no published source that gives a reliable day-by-day timeline for fentanyl withdrawal. What exists is the general opioid timeline and evidence that fentanyl bends it.

Put together, the likely shape is this: the first symptoms can start within hours, and the course can run longer and less predictably than with heroin. The reason is slow clearance. The researchers behind the 2020 study in the table think the week-long urine positives reflect fentanyl stored in fat tissue. Connecting that to how withdrawal runs is our reading, not a measured withdrawal curve.

Is fentanyl withdrawal worse than heroin withdrawal?

Clinicians describe it as harder. The 2024 JAMA Internal Medicine review says fentanyl intensifies withdrawal and cravings. No trial has measured fentanyl and heroin withdrawal head to head in a way that settles “how much worse.” What is settled is that most of the supply is now fentanyl. More than 90 percent of drugs seized by New Jersey law enforcement over a recent two-year period tested positive for fentanyl, per the state’s Commission of Investigation, so assume a powder sold as heroin contains it.

Precipitated withdrawal: the fentanyl-specific risk

Buprenorphine, the drug in Suboxone, binds tightly to opioid receptors and gives a weaker signal. Taken while a full opioid is still on those receptors, it can knock it off and cause sudden, severe withdrawal, called precipitated withdrawal.

Fentanyl makes that harder to avoid. Because it clears slowly, a person can look and feel fully in withdrawal while enough fentanyl remains for buprenorphine to set off a crash. Feeling sick enough is no longer proof of being ready. Our guide to precipitated withdrawal covers what it feels like, how often it happens, and what to do if it does.

Do not attempt a first buprenorphine start alone after fentanyl without talking to a prescriber.

Low-dose starts (micro-induction)

The main workaround has a name. In a low-dose start, sometimes called micro-induction, tiny doses of buprenorphine are stepped up over several days while the full opioid is still on board, so no single dose displaces enough of it to cause a crash. ASAM’s 2023 clinical considerations for people using fentanyl and similar drugs describe low-dose starts as one option, with most of the experience so far in hospitals. The same document says buprenorphine starts may need to be individualized, that withdrawal should be managed proactively before and during the start, and that all forms of opioid agonist treatment should be offered. The 2024 JAMA Internal Medicine review lists low-dose starts with continued opioids, and rapid methadone increases, among the emerging hospital practices.

These are clinician-run protocols, not something to improvise at home. The point of knowing the term is to ask for it.

What helps during fentanyl withdrawal

• Buprenorphine or methadone. Both treat withdrawal and the opioid use disorder underneath it. Methadone is a full agonist, so it does not cause precipitated withdrawal. Our Suboxone, Subutex and Sublocade guide compares the buprenorphine forms.
• Non-opioid comfort medicines. Lofexidine (Lucemyra) is FDA-approved to ease opioid withdrawal symptoms for up to 14 days; its label warns about low blood pressure and slow heart rate, and says plainly that it is not a treatment for opioid use disorder. Clonidine is a related drug; see clonidine vs Klonopin.
• Fluids and symptom relief. For vomiting, diarrhea, cramps, and sleep, prescribed by the team.
• A scored start. Programs measure withdrawal on a structured scale, usually the Clinical Opiate Withdrawal Scale (COWS), instead of guessing.

Medication you keep beats medication you finish. Pooled cohort studies in the BMJ (Sordo, 2017) and JAMA Psychiatry (Santo, 2021) found all-cause death rates about half as high or lower during time on methadone or buprenorphine than during time off them. The Sordo review also found sharply higher death rates in the weeks right after people leave opioid agonist treatment. A detox that ends with no medication and no appointment ends at the most dangerous moment.

Xylazine and medetomidine: the withdrawal inside the withdrawal

Fentanyl in New Jersey often comes mixed with one of two veterinary sedatives, and neither is an opioid.

Xylazine (“tranq”)

The Department of Health alert found xylazine in one-third of suspected heroin and fentanyl seizures in 2022 and 45 percent in the first quarter of 2023. Whether xylazine causes its own withdrawal is still being studied. In a 2025 study of 71 people in a Tennessee inpatient withdrawal unit, those who also tested positive for xylazine showed no detectable difference in withdrawal scores from fentanyl-only patients but somewhat higher blood pressure in the first two days, and were more likely to leave early, though that difference was not statistically significant.

Medetomidine (“rhino tranq”)

This is the newer and more dangerous one. The New Jersey State Commission of Investigation reports that medetomidine had not been seen in New Jersey seizures before 2024, and that from January 2024 to May 2025, state forensic labs found it in 910 cases of suspected heroin.

Stopping it can bring a withdrawal syndrome of its own. The CDC’s April 2026 health advisory lists a fast heart rate, severe high blood pressure, fluctuating alertness, tremor, chest pain, and vomiting that will not stop. In Philadelphia, 165 patients were hospitalized with suspected medetomidine withdrawal between September 2024 and January 2025; 91 percent needed intensive care, and the syndrome did not respond to the medications that had worked for fentanyl and xylazine withdrawal. In July 2026, the New Jersey Poison Information and Education System warned of a rising number of patients across the state with severe medetomidine withdrawal who kept getting worse despite standard opioid treatment.

This is the strongest reason not to ride out fentanyl withdrawal at home in New Jersey right now. Opioid withdrawal is rarely fatal by itself, though tolerance falls within days, so a return to a former dose can be fatal. A medetomidine withdrawal hiding inside it can need an ICU. Tell the detox team if xylazine or medetomidine may be involved, and go to an emergency room for a racing heart that will not settle, chest pain, or confusion.

Naloxone does not reverse either sedative. The CDC still says to give it in a suspected overdose, because fentanyl is involved in most overdoses that include medetomidine.

Can you detox from fentanyl at home?

Three things make withdrawing at home a riskier plan with today’s fentanyl: the timing is less predictable, a self-started buprenorphine dose can trigger precipitated withdrawal, and medetomidine withdrawal can turn dangerous. Add pregnancy, alcohol or benzodiazepine use, or heart disease and the answer is a supervised setting. If you are pregnant, do not stop opioids on your own: ASAM recommends treatment with methadone or buprenorphine rather than withdrawal for pregnant people who are physically dependent on opioids.

The first days after any withdrawal are the highest-risk window. Leave naloxone where someone can reach it, tell them where it is, and do not use alone. Our naloxone guide for families covers how to get it in New Jersey.

In New Jersey

Under New Jersey law P.L.2017, c.28, fully insured New Jersey plans and the State Health Benefits and School Employees’ plans cannot require prior authorization for the first 180 days per plan year of in-network treatment your own physician, psychologist or psychiatrist finds medically necessary, or, during those same 180 days, for outpatient prescription drugs that treat substance use disorder, such as buprenorphine and naltrexone, when that clinician finds them medically necessary. Self-funded employer plans, Medicare and Medicaid are not covered by that rule, so verify with the plan.

NJ FamilyCare covers buprenorphine, methadone, and naltrexone. Residential detox is authorized through the IME for most members, and residential care and opioid treatment programs are scheduled to move into the NJ FamilyCare health plans in January 2027. The opioid detox guide lists New Jersey’s licensed opioid-capable programs and walks through each way to pay.

For help independent of us, the state’s IME Addictions Access Center at 1-844-276-2777 screens NJ FamilyCare and uninsured residents and refers them to treatment, and ReachNJ, the state treatment line, is at 1-844-732-2465. Periscope Behavioral Health, which publishes this site, is opening a medical detox in Hammonton, Atlantic County, expected Summer 2027. Until it opens, Periscope Behavioral Health at (888) 313-3583, our publisher’s admissions line, can talk through options in New Jersey and Florida, including facilities Periscope operates. What a plan covers depends on the plan and the facility’s network status.

Four questions to ask a program

1. How do you start buprenorphine for someone who has been using fentanyl daily? A specific answer is a good sign. Vague reassurance is not.
2. Do you use low-dose starts, and do you offer methadone?
3. How do you recognize and treat medetomidine withdrawal, and when do you send someone to a hospital?
4. Will I leave on medication, with naloxone and a prescriber appointment already booked?

A program that can answer all four has thought about fentanyl as it is sold in New Jersey today, not as heroin was sold a decade ago.